Founded in 2013, Lunit (KRX: 328130) is a global leader on a mission to conquer cancer through AI. Our clinically validated solutions span medical imaging, breast health, and biomarker analysis—empowering earlier detection, smarter treatment decisions, and more precise outcomes across the cancer care continuum. Lunit offers a comprehensive suite spanning risk prediction and early detection to precision oncology. Our FDA-cleared Lunit INSIGHT suite and breast health solutions support cancer screening in thou ...

Core Insights - Lunit has announced a collaboration with Microsoft to enhance the delivery of AI-powered healthcare solutions, particularly in cancer diagnostics and therapeutics [1][2] - The partnership aims to develop integrated solutions that improve clinical workflows and diagnostic consistency in healthcare settings [3][4] Collaboration Highlights - Co-Development of AI Model Customization Service: The collaboration will focus on creating a service that fine-tunes AI models using site-specific clinical data, addressing performance variability across different clinical environments [5] - Leveraging Microsoft's AI Platform: Lunit will utilize Microsoft's AI frameworks to create end-to-end workflow automation tools, enhancing clinical decision-making and operational efficiency [6] Strategic Vision - The collaboration aligns with Lunit's long-term vision to provide scalable and accessible AI solutions integrated into clinical practice, particularly targeting the U.S. market through Microsoft Azure's infrastructure [4][7] - Both companies emphasize the importance of creating an ecosystem that supports the development of intelligent, integrated solutions for radiology and other healthcare areas [7] Company Background - Lunit, founded in 2013, is a leader in AI for cancer diagnostics, with its FDA-cleared Lunit INSIGHT suite used in over 6,500 medical institutions across more than 65 countries [8] - The company is committed to advancing cancer care through AI, with clinical studies published in prestigious journals and presented at major medical conferences [8]